DRUG · Mapped RxNorm record
Pioglitazone
Normalized identity: pioglitazoneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
NCT00231894
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BEHAVIORAL · Unmapped registry intervention
Life style diet group
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetesverified · MONDO: diabetes mellitus
Schizophreniaverified · MONDO: schizophrenia
Insulin Resistanceunresolved
Cognitive Impairmentunresolved
Interventions
Sponsors & collaborators
Nathan Kline Institute for Psychiatric Researchlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00231894 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.